CRAMP administration mediated exacerbated mouse heart injury might be associated with enhancing TLR4 and P2X7R/NLRP3 signaling, since CRAMP administration mediated detrimental effects could be entirely reversed by inhibition of TLR4, P2X7R, and NLRP3 inflammasome [102]. Here, NLRP3 is linked to injury.